This trial will study people with Obstructive Sleep Apnea to try and understand why some people have it and how it affects them.
2 Primary · 14 Secondary · Reporting Duration: 8 weeks
Experimental Treatment
200 Total Participants · 2 Treatment Groups
Primary Treatment: Supplemental Oxygen · No Placebo Group · Phase 2
Age 21 - 65 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:18 - 65 | 100.0% |
Met criteria | 100.0% |